长沙招聘

Strategies and Medical affair Leadership

1. Contribute to Local IPS plan and/or LRR cross functionally.
2. Develops, drive and Lead medical plans under the scope of IPS on behalf of whole medical affairs function.
3. Review and approval Promotional and non promotional materials as a faculty member of materials clearance committee to ensure they are fully aligned with NP4 guideline.
4. Ensure compliance with safety reporting requirements and RMP execution by working with DS&E.
5. Review patients compensation claims by suspected AE for assigned products.
6. Proactively contribute and lead the urgent crisis due to patients complaint.
7. May serve as reprentatives in GMAT(Global Medical Affairs Team) and CPT(China Project team sponsored by development) on behalf of China Medical team.

Medical Affairs Studies (MAS)
1. Define, initiate, coordinate and manage local PMS /Observational studies, PhaseIIIb / IV studies in line with GCP, Local regulations and Global IPS Strategy and plan.
2. Define IIT Strategies and responsible for the whole process of execution of IIT in align with GCP, Local regulations, including contract, payment and publication.
3. Ensures GCP compliance and adherence to Novartis Standard Operating Procedures (SOPs) for conduct of trial activities.
4. Be responsible for approval process(Local, Global, Central EC) approval for Phase IV Studies, PMS.
5. Lead and oversee the Budget of medical affairs studies, responsible for the database management, CSR and publication process and results.
6. Be responsible for Documents Preparation (Study Concept Sheet, Protocol and final study reports and publications ) of Medical affairs studies.
7. Be responsible for design and implantation of other researches such as Chart review, Registries and meta analysis
8. Oversee and management of third party studies, animal/in vitro studies.
9. Responsible for CRO Management(Database and CSR) and Contract management in IIT.
Scientific Information /Messages Management

1. Define and manage on Key scientific messages for assigned product(s) through scientific slides deck, presentations and other tools.
2. Provide comprehensive Medical presentations and training to internal and external customers, for the accurate delivery of messages.
3. Build strong relationship with scientific associations through advisory board meetings, Steering committees.

北京诺华制药有限公司开发、生产和销售治疗多种疾病的创新处方药，涵盖的疾病领域包括：心血管、内分泌、肿瘤、抗感染、风湿疼痛及骨质疏松、移植免疫、中枢神经以及眼科。北京诺华制药曾获得“***雇主”和“最负社会责任的企业”等殊荣。

“诺华”中文取意“承诺中华”，即承诺通过不断创新的产品和服务致力于提高中国人民的健康水平和生活质量。北京诺华制药成立于1987年，总部设在北京，隶属于瑞士诺华公司。

诺华公司致力于为患者及社会提供创新医药保健解决方案，以满足其日益变化的健康需求。2011年，集团持续经营业务实现净销售586亿美元。集团研发投入约为96亿美元（去除减值及摊销后为92亿美元）。诺华集团总部位于瑞士巴塞尔，业务遍及全球140多个国家和地区，拥有124,000位全职员工。诺华集团立足在中国的长期发展，重要战略投资包括位于上海的综合性生物医学研发中心，以及位于北京昌平的制剂生产工厂和江苏常熟的原料药生产工厂。如需更多信息，敬请登录公司网站http://www.novartis.com和http://www.novartis.com.cn。